1. Genentech wants to double its San Francisco footprint — Biotechs with the biggest cash piles — Purdue Pharma wants to pay bonuses even under bankruptcy proceedings — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

BD to buy Bard

Discussion in 'CR Bard' started by anonymous, Apr 24, 2017 at 9:31 AM.

  1. anonymous

    anonymous Guest

    what does it mean for each of the divisions? 300 Million in savings
     
  2. anonymous

    anonymous Guest

    It means that anyone who works at corporate or a division HQ in a non-operations capacity or not in support of operations is fucked (QA).
    Sales geographies will get reviewed to remove redundancy. I'd think that most sales reps will be ok for at least a while due to product knowledge and relationships with customers. DMs and above would go if there is any duplication of responsibilities.
    Product managers and below should be ok from a marketing standpoint. Anyone above is gone.
    Leadership is about to yank the ripcord on their golden parachutes. They took care of themselves.
     
  3. anonymous

    anonymous Guest

    Is BD still filling open positions? I was going to pursue a position that was recently posted.
     
  4. anonymous

    anonymous Guest

    Way to destroy value while the handful corporate executives line their pockets as if the stock run-up was not enough. Guess Bard leadership saw no other way out of all the smoke and mirror, take the money and run....How to you get more EPS margin than gross margin? Lol
     
  5. anonymous

    anonymous Guest

    Please BD you need to do an actual "Anonymous" survey about the culture, happiness, level of engagement and all around attitude of the sales force at Bard. You will not like what you find BD is sitting on something that is about to blow up. It will take one person to kick it off and I can guarantee hundreds (current and ex reps) will follow. Class Action.
     
  6. anonymous

    anonymous Guest

    Come on people. BD is buying the company and Bard is still placing reps who will likely not have jobs in a few months. No products to sell in Biosurgery, PV is being absorbed by BD and reps are going on performance place left and right. What the hell is going on? Some long time people are leaving the company for a reason, they are vested and moving on while there are solid positions available. Stop asking the obvious questions.
     
  7. anonymous

    anonymous Guest

    When are they going to rid of my RM Curry?
     
  8. anonymous

    anonymous Guest

    It will be interesting to see what happens with Bard divisions outside of Access since they're rumored to be staying intact at least for the foreseeable future. Has anyone on the Bard side heard anything similar?
     
  9. anonymous

    anonymous Guest


    Boy this was spot on last year
     
  10. anonymous

    anonymous Guest

    How crazy is this Bard Medical Endourology (BD UCC) ?!? It is officially TOAST.

    If you are interviewing for any of the six open territories in this division - STOP WHAT YOU ARE DOING AND LOOK SOMEWHERE ELSE. (Dallas, Denver, Boston/NY, Seattle/Portland, Florida, and Ohio/Michigan).

    24 reps total in this division. 6 now have left in 2018. And - the most tenured Product Manager has left as well.

    Expect more to be leaving soon, with the loss of the HPG contract. Management has known about us getting kicked off of HPG for over two weeks, but waited until 9/11 to spill the beans. How fitting is that? That's two major contracts we are not on now. The loss of the Premier contract in December of 2017 was the start. You know Vizient will not be renewing things for Bard Endo come 2020.

    But our products (stents, guide wires, baskets, laser fibers) aren't commodities, so we should be able to just switch things over to a Local Contract, and continue on with business as usual...HA! Anyone left here should be on notice that time is short. This place is churning with discontent, low (or no) morale, and is in last place when it comes to market share. Don't let the BDD managers tell you that Olympus is in 4th. They are killing it with their new laser/fiber placement deals. And making headway with disposables because they have capital to leverage in the terms of their own laser boxes, along with their scopes. We have nothing.

    To top it all off, without a doubt BD will be changing the comp plan around, and not in a positive way. Expect total comp to go down. The NSM should be a lot of fun...

    Bye bye BD UCC. Ivan probably has someone looking to off-load this even as you read this.